Prognostic importance of pulmonary hypertension in heart failure with preserved ejection fraction;Importancia pronstica de la hipertensión pulmonar en insuficiencia cardiaca con fraccin de eyección preservada

Revista Clinica Espanola

Volumn 210, Issue 10, 2010, Pages 489-496

  Carrasco Sanchez F J ^a   Ortiz Lopez E ^a   Galisteo Almeda, L ^a   Camacho Vzquez, C ^b   Ruiz Frutos, C ^a   Pujol De La Llave, E ^a  

^a HOSPITAL JUAN RAMÓN JIMÉNEZ   (Spain)

^b UNIVERSITY OF HUELVA   (Spain)

Author keywords

Heart failure; Mortality; Preserved ejection fraction; Pulmonary artery systolic pressure; Pulmonary hypertension

Indexed keywords

ARTICLE; FOLLOW UP; HAZARD RATIO; HEART ATRIUM PRESSURE; HEART EJECTION FRACTION; HEART FAILURE; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; KAPLAN MEIER METHOD; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MORTALITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PULMONARY HYPERTENSION; SYSTOLIC BLOOD PRESSURE; TRICUSPID VALVE REGURGITATION; AGED; FEMALE; HEART STROKE VOLUME; MALE; PATHOPHYSIOLOGY; PROSPECTIVE STUDY;

AGED; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION, PULMONARY; MALE; PROGNOSIS; PROSPECTIVE STUDIES; STROKE VOLUME;

EID: 78049420286     PISSN: 00142565     EISSN: 15781860     Source Type: Journal    
DOI: 10.1016/j.rce.2010.04.019     Document Type: Article

References (26)

1. S.V. Abramson, J.F. Burke, J.J. Kelly Jr, JG III Kitchen, MJ Dougherty, and DF Yih Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy Ann Intern Med 116 1992 888 895
2. J. Kjaergaard, D. Akkan, K.K. Iversen, E Kjoller, L Kober, and C Torp-Pedersen Prognostic importance of pulmonary hypertension in patients with heart failure Am J Cardiol 99 2007 1146 1150
3. K.K. Khush, G. Tasissa, J. Butler, D. McGlothlin, and M.T. De Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database Am Heart J 157 2009 1026 1034
4. R.M. Zakir, A. Al-Dehneh, J. Maher, M. Saric, and R.L. Berkowitz Right ventricular failure in patients with preserved ejection fraction and diastolic dysfunction: an underrecognized clinical entity Congest Heart Fail 13 2007 164 169
5. C.S. Lam, V.L. Roger, R.J. Rodeheffer, B.A. Borlaug, F.T. Enders, and M.M. Redfield Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study J Am Coll Cardiol 53 2009 1119 1126
6. J.R. Aragam, E.D. Folland, D. Lapsley, S. Sharma, S.F. Khuri, and G.V. Sharma Cause and impact of pulmonary hypertension in isolated aortic stenosis on operative mortality for aortic valve replacement in men Am J Cardiol 69 1992 1365 1367
7. B.P. Shapiro, M.D. McGoon, and M.M. Redfield Unexplained pulmonary hypertension in elderly patients Chest 131 2007 94 100
8. C. Tribouilloy, D. Rusinaru, L. Leborgne, H Mahjoub, C Szymanski, and D Houpe In-hospital mortality and prognostic factors in patients admitted for new-onset heart failure with preserved or reduced ejection fraction: a prospective observational study Arch Cardiovasc Dis 101 2008 226 234
9. K. Dickstein, A. Cohen-Solal, G. Filippatos, JJ McMurray, P Ponikowski, and PA Poole-Wilson ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 The Task Force for the Diagnosis and Treatment of acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 2008 2388 2442
10. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 2002 S46 S75
11. J. Sanz, L. Fernández-Friera, and S. Moral Imaging Techniques and the Evaluation of the Right Heart and the Pulmonary Circulation Rev Esp Cardiol 63 2010 209 223
12. M. McGoon, D. Gutterman, V. Steen, R Barst, DC McCrory, and TA Fortin Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines Chest 126 2004 14S 34S (Pubitemid 38932340)
13. T.P. Fitzgibbons, T.E. Meyer, and G.P. Aurigemma Mortality in diastolic heart failure: an update Cardiol Rev 17 2009 51 55
14. B.M. McQuillan, M.H. Picard, M. Leavitt, and A.E. Weyman Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects Circulation 104 2001 2797 2802
15. C.S. Lam, B.A. Borlaug, G.C. Kane, F.T. Enders, R.J. Rodeheffer, and M.M. Redfield Age-associated increases in pulmonary artery systolic pressure in the general population Circulation 119 2009 2663 2670
16. L. Perez de Isla, V. Cañadas, L. Contreras, C. Almeria, J.L. Rodrigo, and A.L. Aubele Diastolic heart failure in the elderly: in-hospital and long-term outcome after the first episode Int J Cardiol 134 2009 265 270
17. E. Weitzenblum, C. Hirth, A. Ducolone, R. Mirhom, J. Rasaholinjanahary, and M. Ehrhart Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease Thorax 36 1981 752 758 (Pubitemid 12249743)
18. F. Gustafsson, C. Torp-Pedersen, B. Brendorp, M. Seibaek, H. Burchardt, and L. Kober Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function Eur Heart J 24 2003 863 870 (Pubitemid 36528566)
19. D. Rusinaru, O. Buiciuc, D. Houpe, and C. Tribouilloy Renal function and long-term survival after hospital discharge in heart failure with preserved ejection fraction Int J Cardiol 2009
20. A.S. Levey, T. Greene, J.W. Kusek, and G.J. Beck A simplified equation to predict glomerular filtration rate from serum creatinine J Am Soc Nephrol 11 2000 A08028
21. D. Rusinaru, O. Buiciuc, L. Leborgne, M. Slama, Z. Massy, and C. Tribouilloy Relation of serum sodium level to long-term outcome after a first hospitalization for heart failure with preserved ejection fraction Am J Cardiol 103 2009 405 410
22. W.J. Paulus, C. Tschope, J.E. Sanderson, C Rusconi, FA Flachskampf, and FE Rademakers How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology Eur Heart J 28 2007 2539 2550
23. J.L. Bouchard, G.P. Aurigemma, J.C. Hill, C.A. Ennis, and D.A. Tighe Usefulness of the pulmonary arterial systolic pressure to predict pulmonary arterial wedge pressure in patients with normal left ventricular systolic function Am J Cardiol 101 2008 1673 1676
24. R.M. Califf, K.F. Adams, W.J. McKenna, M Gheorghiade, BF Uretsky, and SE McNulty A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST) Am Heart J 134 1997 44 54
25. I. Anand, J. McMurray, J.N. Cohn, MA Konstam, T Notter, and K Quitzau Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial Lancet 364 2004 347 354
26. Evaluating the Effectiveness of Sildenafil at Improving Health Outcomes and Exercise Ability in People With Diastolic Heart Failure (The RELAX Study). Disponible en: http://clinicaltrialsgov/ct2/show/NCT00763867?term= RELAX&rank=1 2010; Accessed January 28.